Tag Archives: intellectual property

Duties And Responsibilities Of A Corporate Fed. R. Civ. P. 30(B)(6) Witness

The following is from the Robins, Kaplan, Miller & Ciresi newsletter BuLITS and written by Ron Schutz Case: In re Neurontin Antitrust Litigation, 2011 U.S. Dist. LEXIS 62032, MDL No. 1479, Master File No. 02-1390 (D.N.J. 6/9/2011). Facts: Direct purchasers … Continue reading

Posted in Litigation Issues | Tagged , , , , , | Leave a comment

Myriad Petition For Rehearing Denied

On September 13, 2011, the Fed. Cir. panel in AMP v. Myriad denied AMP’s (read ACLU’s) petition for rehearing by the panel. (A copy of the petition can be found at the end of this post.) In challenging the holding … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | Leave a comment

Fifty Ways To Leave Your Lover And Nine Ways To Attack Patents

As a “quick guide” to the Patent Reform Bill, H.R. 1249, that will soon become law, these are the sections of the Act and of the present statute that will all be, or remain effective, upon enactment, to facilitate blocking … Continue reading

Posted in Patent Reform Legislation | Tagged , , , , , , , , , , , | Leave a comment

Classen Immunotherapeutics v. Biogen Idec: Corrected Opinion Likely?

On August 31, 2011, a three-judge panel of the Fed. Cir. (Rader, Newman, Moore) revisited the court’s 2009 summary affirmance that the claims of three Classen patents were not directed to patentable subject matter. (A copy is at the end … Continue reading

Posted in Patent Eligible Subject Matter | Tagged , , , , , , , , , , , , | 3 Comments